Early Genetic Analysis of Advanced and Metastatic Biliary Tract Cancer to Optimize Second-Line Therapy
New recommendations on current best treatment options favor targeted therapies for specific genetic alterations in tumor cells Krems (Austria), 21. September, 2023: Experts from Austria have now published new recommendations on the current best treatment options for advanced or metastatic biliary tract cancer. The new consensus favors personalized second-line therapies that target specific genetic alterations […]